mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.01 |
mRNA |
HG-5-88-01 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.01 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
BMS-536924 |
GDSC1000 |
pan-cancer |
AAC |
-0.083 |
0.01 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.02 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.02 |
mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
0.65 |
0.02 |